Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for ...
Leadership
Krishna Vaddi D.V.M., Ph.D.Founder
Founder, CEO & Director
Bryant David Lim J.D.
CFO, Chief Legal Officer & Corporate Secretary
Peggy A. Scherle Ph.D.
Chief Scientific Officer
Aimee Crombie Ph.D.
Senior VP and Head of Strategic Planning & Operations
